Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review
Kin Israel Notarte, Jesus Alfonso Catahay, Jacqueline Veronica Velasco, et al.
EClinicalMedicine (2022) Vol. 53, pp. 101624-101624
Open Access | Times Cited: 405

Showing 26-50 of 405 citing articles:

Risk of long COVID main symptoms after SARS-CoV-2 infection: a systematic review and meta-analysis
Zoe Marjenberg, Sean X. Leng, Carlo Tascini, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 39
Postacute Sequelae of SARS-CoV-2 in Children
Suchitra Rao, Rachel S. Gross, Sindhu Mohandas, et al.
PEDIATRICS (2024) Vol. 153, Iss. 3
Closed Access | Times Cited: 34
Short- and long-term neuropsychiatric outcomes in long COVID in South Korea and Japan
Sun Young Kim, Hayeon Lee, Jinseok Lee, et al.
Nature Human Behaviour (2024) Vol. 8, Iss. 8, pp. 1530-1544
Closed Access | Times Cited: 27
Vaccine Effectiveness Against Long COVID in Children
Hanieh Razzaghi, Christopher B. Forrest, Kathryn Hirabayashi, et al.
PEDIATRICS (2024) Vol. 153, Iss. 4
Closed Access | Times Cited: 24
Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection
Ivan Chun Hang Lam, Ran Zhang, Kenneth K. C. Man, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 24
The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches
Roxana Gheorghiţă, Iuliana Șoldănescu, Andrei Lobiuc, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 20
Characteristics of long COVID and the impact of COVID-19 vaccination on long COVID 2 years following COVID-19 infection: prospective cohort study
Yoonjung Kim, Sohyun Bae, Hyun‐Ha Chang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Prevalence and Factors Associated with Long COVID Symptoms among U.S. Adults, 2022
Kimberly H. Nguyen, Yingjun Bao, Julie Mortazavi, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 99-99
Open Access | Times Cited: 15
Cognitive dysfunction after covid-19
Emma Ladds, Julie Darbyshire, Nawar Diar Bakerly, et al.
BMJ (2024), pp. e075387-e075387
Open Access | Times Cited: 14
SARS-COV-2 re-infection and incidence of post-acute sequelae of COVID-19 (PASC) among essential workers in New York: a retrospective cohort study
Tesleem Kayode Babalola, Sean Clouston, Zennur Sekendiz, et al.
The Lancet Regional Health - Americas (2025) Vol. 42, pp. 100984-100984
Closed Access | Times Cited: 1
The Epidemiology of Long Coronavirus Disease in US Adults
McKaylee Robertson, Saba A Qasmieh, Sarah Kulkarni, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 9, pp. 1636-1645
Open Access | Times Cited: 66
Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post‐acute sequelae of COVID‐19
Christoph Schultheiß, Edith Willscher, Lisa Paschold, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 62
Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations
Valentina Bonetto, Laura Pasetto, Ilaria Lisi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 56
Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19
Chisa Matsumoto, Shigeru Shibata, Takuya Kishi, et al.
Hypertension Research (2022) Vol. 46, Iss. 3, pp. 601-619
Open Access | Times Cited: 41
Effects of COVID-19 on cognition and brain health
Sijia Zhao, Sofia Toniolo, Adam Hampshire, et al.
Trends in Cognitive Sciences (2023) Vol. 27, Iss. 11, pp. 1053-1067
Open Access | Times Cited: 35
Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
Grace Kenny, Liam Townsend, Stefano Savinelli, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 34
Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study
Xianming Zhu, Kelly A. Gebo, Alison G. Abraham, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 9, pp. e692-e703
Open Access | Times Cited: 34
Post COVID-19 condition after Wildtype, Delta, and Omicron SARS-CoV-2 infection and prior vaccination: Pooled analysis of two population-based cohorts
Tala Ballouz, Dominik Menges, Marco Kaufmann, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0281429-e0281429
Open Access | Times Cited: 33
Post-COVID Syndrome in Adults—An Overview
Rüdiger E. Scharf, Juan‐Manuel Anaya
Viruses (2023) Vol. 15, Iss. 3, pp. 675-675
Open Access | Times Cited: 33
Diagnosis and management of post-COVID (Long COVID) in children: a moving target
Rosa Morello, Laura Martino, Danilo Buonsenso
Current Opinion in Pediatrics (2023) Vol. 35, Iss. 2, pp. 184-192
Open Access | Times Cited: 32
Mitigating neurological, cognitive, and psychiatric sequelae of COVID-19-related critical illness
Pratik P. Pandharipande, Shawniqua Williams Roberson, Fiona E. Harrison, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 8, pp. 726-738
Open Access | Times Cited: 30
B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity
Dennis Lapuente, Thomas Winkler, Matthias Tenbusch
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 144-158
Open Access | Times Cited: 29
Post-COVID-19 syndrome and quality of life impairment in severe COVID-19 Mexican patients
Carla Marina Román-Montes, Yesenia C Flores-Soto, Guillermo Arturo Guaracha-Basáñez, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 28
Prolonged T-cell activation and long COVID symptoms independently associate with severe COVID-19 at 3 months
Marianna Santopaolo, Michaela Gregorová, Fergus Hamilton, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 28
Post-Acute COVID-19 Joint Pain and New Onset of Rheumatic Musculoskeletal Diseases: A Systematic Review
Jacopo Ciaffi, Elena Vanni, Luana Mancarella, et al.
Diagnostics (2023) Vol. 13, Iss. 11, pp. 1850-1850
Open Access | Times Cited: 26

Scroll to top